News Summary: Report details Medtronic tactics

Published



SPIN DOCTORS? Medical device maker Medtronic Inc. helped write and edit medical journal articles attributed to outside physicians, which downplayed the risks of the company’s best-selling bone graft, according to Senate investigators.

CLOSED-DOOR OPERATIONS: The world’s largest device maker did not disclose its role in shaping 13 key studies of InFuse, including serious risks such as male sterility, infection and increased back and leg pain.

Trusted reporting.Unlimited access.

Subscribe for full access to Washington Examiner coverage, expert political analysis, and subscriber-only journalism.

Get Unlimited Access

Already a member? Log in

Cancel anytime.